Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial-Reference-Cited by-同舟云学术

Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial

Published:2023-06 Issue:6 Volume:8 Page:523-532
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Israelsen Mads,Madsen Bjørn Stæhr,Torp Nikolaj,Johansen Stine,Hansen Camilla Dalby,Detlefsen Sönke,Andersen Peter,Hansen Johanne Kragh,Lindvig Katrine Prier,Rasmussen Ditlev Nytoft,Thorhauge Katrine Holtz,Kjærgaard Maria,Karsdal Morten,Hansen Torben,Arumugam Manimozhiyan,Trebicka Jonel,Thiele Maja,Krag Aleksander,Anastasiadou Ema,Arumugam Manimozhian,Bork Peer,Hansen Torben,Henrar Roland,Israelsen Hans,Karsdal Morten,Legido-Quigley Cristina,Melberg Hans Olav,Thiele Maja,Trebicka Jonel,Krag Aleksander,Bork Peer,Mann Mathias,Matthijnssens Jelle,Krag Aleksander,Hansen Torben

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. Burden of liver diseases in the world;Asrani;J Hepatol,2019

2. Trends and the course of liver cirrhosis and its complications in Germany: nationwide population-based study (2005 to 2018);Gu;Lancet Reg Health Eur,2021

3. Collagen proportionate area predicts clinical outcomes in patients with alcohol-related liver disease;Israelsen;Aliment Pharmacol Ther,2020

4. Screening for liver fibrosis in the general population: a call for action;Ginès;Lancet Gastroenterol Hepatol,2016

5. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease;Rasmussen;J Hepatol,2021

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of rifaximin in liver diseases;Biomedicine & Pharmacotherapy;2024-09

2. Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis;Clinics in Liver Disease;2024-08

3. Research Priorities and Future Landscape of Clinical Trials in Alcohol-Associated Liver Disease;Clinics in Liver Disease;2024-07

4. Alcohol-associated liver disease: Emerging therapeutic strategies;Hepatology;2024-06-26

5. Digestive dynamics: Unveiling interplay between the gut microbiota and the liver in macronutrient metabolism and hepatic metabolic health;Physiological Reports;2024-06